PUBLISHER: The Business Research Company | PRODUCT CODE: 1945512
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945512
Mechanical circulatory support devices are sophisticated medical technologies designed to assist or replace the heart's pumping function in patients with severe heart failure or other cardiac conditions. These devices ensure adequate blood flow and oxygen delivery to vital organs when the heart is unable to perform effectively. They are employed as life-saving interventions to stabilize patients, enhance quality of life, and, in some cases, act as a bridge to heart transplantation or recovery.
The primary types of mechanical circulatory support devices include the intra-aortic balloon pump, ventricular assist device, total artificial heart, and extracorporeal membrane oxygenation. An intra-aortic balloon pump assists the heart by inflating and deflating a balloon within the aorta, improving blood flow and reducing cardiac workload. The main technologies used are pulsatile flow devices and non-pulsatile flow devices. These devices find applications in cardiac surgery, heart failure management, myocardial infarction, and cardiogenic shock, and are utilized by a range of end users including hospitals, ambulatory surgical centers, specialty clinics, and others.
Tariffs are impacting the mechanical circulatory support devices market by increasing the cost of imported components such as advanced pumps, ECMO systems, and electronic control units. Segments like ventricular assist devices and total artificial hearts are most impacted, with regions including Asia-Pacific and Europe facing higher import duties. This has led to increased production costs and slower adoption rates in certain areas. Positively, tariffs have encouraged local manufacturing, investment in domestic production, and innovation in cost-efficient cardiac support technologies.
The mechanical circulatory support devices market research report is one of a series of new reports from The Business Research Company that provides mechanical circulatory support devices market statistics, including mechanical circulatory support devices industry global market size, regional shares, competitors with a mechanical circulatory support devices market share, detailed mechanical circulatory support devices market segments, market trends and opportunities, and any further data you may need to thrive in the mechanical circulatory support devices industry. This mechanical circulatory support devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The mechanical circulatory support devices market size has grown rapidly in recent years. It will grow from $3.47 billion in 2025 to $3.82 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to limited availability of advanced circulatory support devices, reliance on conventional intra-aortic balloon pumps, increasing prevalence of heart failure, rising cardiac surgery procedures, lack of standardized training for device implantation.
The mechanical circulatory support devices market size is expected to see strong growth in the next few years. It will grow to $5.59 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to technological advancements in pulsatile and non-pulsatile flow devices, growth in minimally invasive cardiac interventions, increasing adoption of left and biventricular assist devices, expansion of hospitals and specialty cardiac centers, rising investment in cardiac care research and development. Major trends in the forecast period include rising adoption of ventricular assist devices and total artificial hearts, growth in cardiac surgery and heart failure management procedures, increasing use of extracorporeal membrane oxygenation (ecmo) systems, focus on minimally invasive and percutaneous device implementation, enhanced regulatory compliance and safety standards for cardiac devices.
The increasing prevalence of heart failure is expected to drive the growth of the mechanical circulatory support devices market in the coming years. Heart failure is a chronic condition in which the heart cannot pump sufficient blood to meet the body's needs. This condition is becoming more common due to the aging population, as older adults are more susceptible to cardiovascular diseases and related complications. Mechanical circulatory support devices assist the heart by improving blood circulation, easing the workload on a weakened heart, and enhancing overall cardiac function. For example, in September 2024, the Heart Failure Society of America (HFSA), a US-based non-profit organization, reported that heart failure currently affects 6.7 million Americans over the age of 20. This number is projected to rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. This increasing prevalence of heart failure is thus driving demand for mechanical circulatory support devices.
Companies in the mechanical circulatory support devices market are developing advanced technologies, such as magnetically levitated rotor (MAGLEV) technology, to provide more efficient and reliable devices that improve heart function and patient survival. MAGLEV technology uses magnetic fields to suspend and rotate a rotor without physical contact, reducing friction and wear for smoother and longer-lasting device performance. For instance, in July 2024, BiVACOR Inc., a US-based clinical-stage medical device company, performed the first-in-human implantation of its Total Artificial Heart (TAH). This device is designed to fully replace both ventricles in patients with severe biventricular or univentricular heart failure who are not eligible for conventional left ventricular assist devices, offering a crucial bridge-to-transplant solution and the potential to enhance survival and quality of life for patients facing limited treatment options due to donor heart scarcity.
In November 2024, magAssist Co., Ltd., a China-based medical device company, partnered with Zhongshan Hospital (Fudan University) to co-develop NyokAssist, a percutaneous ventricular assist device designed to deliver temporary circulatory support for patients experiencing acute heart failure. Through this collaboration, magAssist and Zhongshan Hospital aim to integrate clinical expertise with advanced medical device technology to enable minimally invasive interventions and rapid hemodynamic stabilization for critically ill patients. Zhongshan Hospital (Fudan University) is a China-based hospital and research institution specializing in cardiovascular medicine and clinical research.
Major companies operating in the mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, LivaNova PLC, Magenta Medical Ltd., CorWave SA, Jarvik Heart Inc., Carmat SAS, Procyrion Inc., BiVACOR Inc., Evaheart Inc., ReliantHeart Inc., SynCardia Systems LLC, Berlin Heart GmbH, NovaPump GmbH, CardiacAssist Inc., Circulite Medical Inc., Windmill Cardiovascular Systems Inc., NuPulseCV Inc., FineHeart SAS
North America was the largest region in the mechanical circulatory support devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the mechanical circulatory support devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The mechanical circulatory support devices market consists of revenues earned by entities by providing services such as technical support, patient monitoring, device calibration, repair, clinical consultation, performance testing, and emergency assistance. The market value includes the value of related goods sold by the service provider or included within the service offering. The mechanical circulatory support devices market also includes sales of intra-aortic balloon pump, ventricular assist device, total artificial heart, extracorporeal membrane oxygenation, pulsatile flow device, non-pulsatile flow device, and implantable device. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mechanical Circulatory Support Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses mechanical circulatory support devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for mechanical circulatory support devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mechanical circulatory support devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.